| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4207884 | Clinics in Chest Medicine | 2007 | 9 Pages |
Abstract
Pulmonary hypertension (PH) denotes a poor prognosis in patients with left-sided heart disease. No study has demonstrated long-term benefit from PH drugs such as prostanoids, endothelin antagonists, and phosphodiesterase-5 inhibitors. In some cases, cautious use of PH drugs may be indicated. However, theoretic and practical concerns limit any formal recommendations.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Ronald J. MD,